Selexis Appoints Roland Hoffmann-Hecht, PhD, as Chief Busine

GENEVA--(BUSINESS WIRE)--Jun 1, 2021--
Selexis SA, a JSR Life Sciences company, has named seasoned business development executive Roland Hoffmann-Hecht, PhD, as its new chief business officer. As a member of the company’s executive leadership team, Dr. Hoffmann-Hecht will be responsible for all corporate and business development activities and will report directly to Selexis Chief Executive Officer Dirk Lange.
(Photo: Business Wire)
“We are fortunate to welcome Roland to our executive leadership team given his expansive career in contract development and manufacturing organizations (CDMOs) serving the biopharmaceuticals industry and demonstrated success building valuable relationships with partners,” said Mr. Lange. “His highly relevant skills and experience, coupled with his scientific and industry knowledge, will be invaluable to Selexis as we bolster our leading position in cell line development and ensure the continued success of our “Gene-to-GMP in 9 Months” and SKI (Selexis KBI Integrated) programs, which we offer in conjunction with fellow JSR Life Sciences affiliate company, KBI Biopharma.”

Related Keywords

Switzerland , Homburg , Switzerland General , Rentschler Biotechnologie Gmb , Polpharma Biologics , Dirk Lange , Robert Meister , Mike Beyer , Roland Hoffmann Hecht , University Of Homburg , Linkedin , Twitter , Sam Brown Inc , Institute For Human Genetics , Company Inquiries For Selexis , Corporate Communications , Facebook , Life Sciences , Selexis Chief Executive Officer Dirk , Business Wire , Rentschler Biotechnologie , Medical University , Human Genetics , Media Inquiries , Money , Ational , சுவிட்சர்லாந்து , ஹோம்பர்க் , சுவிட்சர்லாந்து ஜநரல் , டர்க் லாங்கே , ராபர்ட் மைஸ்டர் , மைக் பேயர் , சென்டர் , ட்விட்டர் , சாம் பழுப்பு இன்க் , நிறுவனம் க்கு மனிதன் ஜெநெடிக்ஸ் , பெருநிறுவன தகவல்தொடர்புகள் , முகநூல் , வாழ்க்கை அறிவியல் , வணிக கம்பி , மருத்துவ பல்கலைக்கழகம் , மனிதன் ஜெநெடிக்ஸ் , மீடியா விசாரணைகள் , பணம் ,